SOPHiA GENETICS (SOPH) Assets (2020 - 2025)

SOPHiA GENETICS (SOPH) has 6 years of Assets data on file, last reported at $163.0 million in Q4 2025.

• For the quarter ending Q4 2025, Assets rose 4.97% year-over-year to $163.0 million; the trailing twelve-month figure through Dec 2025 stood at $163.0 million (up 4.97% YoY), and the FY2025 full-year result was $163.0 million, up 4.97% from the prior year.
• Assets steadied at $163.0 million in Q4 2025, from $163.5 million in the prior quarter.
• In the past five years, Assets ranged from a high of $334.9 million in Q3 2021 to a low of $104.0 million in Q2 2021.
• A 5-year average of $212.7 million and a median of $205.9 million in 2023 frame the typical range for Assets.
• Peak annual rise in Assets reached 166.45% in 2022, while the deepest fall reached 25.18% in 2022.
• Tracing SOPH's Assets over 5 years: stood at $320.2 million in 2021, then dropped by 23.84% to $243.8 million in 2022, then decreased by 15.45% to $206.2 million in 2023, then fell by 24.66% to $155.3 million in 2024, then rose by 4.97% to $163.0 million in 2025.
• Business Quant data shows SOPH's Assets at $163.0 million in Q4 2025, $163.5 million in Q3 2025, and $177.6 million in Q2 2025.